Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis

Genes and Development

Volumn 17, Issue 4, 2003, Pages 488-501

  Gunther, Edward J ^a,b   Moody, Susan E ^a,b   Belka, George K ^a,b   Hahn, Kristina T ^a,b   Innocent, Nathalie ^a,b   Dugan, Katherine D ^a,b   Cardiff, Robert D ^c   Chodosh, Lewis A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inducible transgenic animals; Mammary gland; p53; Wnt

Indexed keywords

DOXYCYCLINE; PROTEIN P53;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE ACTIVATION; LUNG METASTASIS; MAMMARY GLAND; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR REGRESSION; WNT GENE;

ADENOCARCINOMA; ANEUPLOIDY; ANIMALS; DOWN-REGULATION; DOXYCYCLINE; FEMALE; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASM RECURRENCE, LOCAL; NEOPLASM REGRESSION, SPONTANEOUS; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; WNT PROTEINS; WNT1 PROTEIN; ZEBRAFISH PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 0037442760     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1051603     Document Type: Article

References (40)

1. Bergstein, I. and Brown, A.M.C. 1999. WNT genes and breast cancer. In Breast cancer: Molecular genetics, pathogenesis, and therapeutics (ed. A.M. Bowcock), pp. 181-198. Humana Press, Totowa, NJ.
2. Bienz, M. and Clevers, H. 2000. Linking colorectal cancer to Wnt signaling. Cell 103: 311-320.
3. Bunz, F., Hwang, P.M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K.W., and Vogelstein, B. 1999. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest. 104: 263-269.
4. Cadigan, K.M. and Nusse, R. 1997. Wnt signaling: A common theme in animal development. Genes & Dev. 11: 3286-3305.
5. Cardiff, R.D., Sinn, E., Muller, W., and Leder, P. 1991. Transgenic oncogene mice. Tumor phenotype predicts genotype. Am. J. Pathol. 139: 495-501.
6. Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. 1999. Essential role for oncogenic Ras in tumour maintenance. Nature 400: 468-472.
7. D'Cruz, C.M., Gunther, E.J., Boxer, R.B., Hartman, J.L., Sintasath, L., Moody, S.E., Cox, J.D., Ha, S.I., Belka, G.K., Golant, A., et al. 2001. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat. Med.7: 235-239.
8. Donehower, L.A., Godley, L.A., Aldaz, C.M., Pyle, R., Shi, Y.P., Pinkel, D., Gray, J., Bradley, A., Medina, D., and Varmus, H.E. 1995. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes & Dev. 9: 882-895.
9. Donehower, L.A., Godley, L.A., Aldaz, C.M., Pyle, R., Shi, Y.P., Pinkel, D., Gray, J., Bradley, A., Medina, D., and Varmus, H.E. 1996. The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model. Prog. Clin. Biol. Res. 395: 1-11.
10. Evan, G.I. and Vousden, K.H. 2001. Proliferation, cell cycle, and apoptosis in cancer. Nature 411: 342-348.
11. Felsher, D.W. and Bishop, J.M. 1999. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4: 199-207.
12. Fisher, G.H., Wellen, S.L., Klimstra, D., Lenczowski, J.M., Tichelaar, J.W., Lizak, M.J., Whitsett, J.A., Koretsky, A., and Varmus, H.E. 2001. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes & Dev. 15: 3249-3262.
13. Gardner, H.P., Belka, G.K., Wertheim, G.B., Hartman, J.L., Ha, S.I., Gimotty, P.A., Marquis, S.T., and Chodosh, L.A. 2000. Developmental role of the SNF1-related kinase Hunk in pregnancy-induced changes in the mammary gland. Development 127: 4493-4509.
14. Gorre, M.E. and Sawyers, C.L. 2002. Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia. Curr. Opin. Hematol. 9: 303-307.
15. Gunther, E.J., Belka, G.K., Wertheim, G.B., Wang, J., Hartman, J.L., Boxer, R.B., and Chodosh, L.A. 2002. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J. 16: 283-292.
16. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B., and Kinzler, K.W. 1998. Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
17. Huettner, C.S., Zhang, P., Van Etten, R.A., and Tenen, D.G. 2000. Reversibility of acute B-cell leukemia induced by BCR-ABL1. Nat. Genet. 24: 57-60.
18. Imbert, A., Eelkema, R., Jordan, S., Feiner, H., and Cowin, P. 2001. Delta N89 β-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J. Cell Biol. 153: 555-568.
19. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T., and Weinberg, R.A. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7.
20. Jain, M., Arvanitis, C., Chu, K., Dewey, W., Leonhardt, E., Trinh, M., Sundberg, C.D., Bishop, J.M., and Felsher, D.W. 2002. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297: 102-104.
21. Johnstone, R.W., Ruefli, A.A., and Lowe, S.W. 2002. Apoptosis: A link between cancer genetics and chemotherapy. Cell 108: 153-164.
22. Jonsson, M., Dejmek, J., Bendahl, P.-O., and Andersson, T. 2002. Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res. 62: 409-416.
23. Kinzler, K.W. and Vogelstein, B. 1996. Lessons from hereditary colorectal cancer. Cell 87: 159-170.
24. Li, Y., Hively, W.P., and Varmus, H.E. 2000. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19: 1002-1009.
25. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A., and Jacks, T. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
26. Lowe, S.W., Bodis, S., McClatchey, A., Remington, L., Ruley, H.E., Fisher, D.E., Housman, D.E., and Jacks, T. 1994. p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810.
27. Marquis, S.T., Rajan, J.V., Wynshaw-Boris, A., Xu, J., Yin, G.Y., Abel, K.J., Weber, B.L., and Chodosh, L.A. 1995. The developmental pattern of Brcal expression implies a role in differentiation of the breast and other tissues. Nat. Genet. 11: 17-26.
28. Michaelson, J.S. and Leder, P. 2001. β-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 20: 5093-5099.
29. Miyoshi, K., Shillingford, J.M., Le Provost, F., Gounari, F., Bronson, R., von Boehmer, H., Taketo, M.M., Cardiff, R.D., Hennighausen, L., and Khazaie, K. 2002. Activation of β-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc. Natl. Acad. Sci. 99: 219-224.
30. Moser, A.R., Mattes, E.M., Dove, W.F., Lindstrom, M.J., Haag, J.D., and Gould, M.N. 1993. ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc. Natl. Acad. Sci. 90: 8977-8981.
31. Munn, R.J., Webster, M., Muller, W.J., and Cardiff, R.D. 1995. Histopathology of transgenic mouse mammary tumors (a short atlas). Semin. Cancer Bio. 6: 153-158.
32. Nusse, R. and Varmus, H.E. 1982. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99-109.
33. Polakis, P. 2000. Wnt signaling and cancer. Genes & Dev. 14: 1837-1851.
34. Roose, J., Huls, G., van Beest, M., Moerer, P., van der Horn, K., Goldschmeding, R., Logtenberg, T., and Clevers, H. 1999. Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1. Science 285: 1923-1926.
35. Siegel, P.M., Hardy, W.R., and Muller, W.J. 2000. Mammary gland neoplasia: Insights from transgenic mouse models. Bioessays 22: 554-563.
36. Taipale, J. and Beachy, P.A. 2001. The Hedgehog and Wnt signalling pathways in cancer. Nature 411: 349-354.
37. Tsukamoto, A.S., Grosschedl, R., Guzman, R.C., Parslow, T., and Varmus, H.E. 1988. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619-625.
38. Ugolini, F., Charafe-Jauffret, E., Bardou, V.-J., Geneix, J., Adelaide, J., Labat-Moleur, F., Penault-Llorca, F., Longy, M., Jacquemier, J., Birnbaum, D., et al. 2001. Wnt pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene 20: 5810-5817.
39. Vindelov, L.L. 1977. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. Virchows Arch. B Cell Pathol. 24: 227-242.
40. Yu, J.L., Rak, J.W., Coomber, B.L., Hicklin, D.J., and Kerbel, R.S. 2002. Effect of p53 status on tumor response to antiangiogenic therapy. Science 295: 1526-1528.